Uvisa Health ApS: Financial statements 2023
CVR: 42444383
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Uvisa Health ApS (CVR 42444383) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 118,819 and a net result of DKK -837,827 compared with DKK 61,602 the year before. That is an increase of 63% compared with the year before. Equity in the 2023 report amounted to DKK -523,380. The company had 4 employees in the financial year.
- Gross Profit
- DKK 118,819
- Profit/Loss
- DKK -837,827
- Equity
- DKK -523,380
- Total Assets
- DKK 815,761
- Employees
- 4
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of August 7, 2023, Karoline Tetlie Akerjordet has joined the board of directors of Uvisa Health ApS.
As of August 7, 2023, Jens Staahl Weirsøe has joined the board of directors of Uvisa Health ApS.
Uvisa Health ApS has published its annual report for 2022. Gross profit came to DKK 72,906, and the net result was DKK 61,602.
About Uvisa Health ApS
Uvisa Health ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ella Jade Smoraczewska Harris. The board consists of Jesper Ahlmann Funding Andersen (chair), Malene Schrøder, Ella Jade Smoraczewska Harris and Erica Perrier. The company's owners include BORRING HOLDING A/S, Majoha ApS and Harris Holdings ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -3,331,233 and a net result of DKK -5,624,368 compared with DKK -3,028,785 the year before. Equity in the 2025 report amounted to DKK -5,067,530.